Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Ранг среди акций #19170
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Цена акции
$1.62
Последняя синхронизация: 2026-08-25
Рыночная капитализация
$172.47M
Изменение (1 день)
-3.57%
Изменение (1 год)
446.74%
Страна
US
Торговля Cypherpunk Technologies Inc. (CYPH)

Категория

История цены акций Cypherpunk Technologies Inc. (CYPH)
Наивысшая цена закрытия: $0.94 2026-08-01

Наименьшая цена закрытия: $75.65 2017-01-01
История цены акций Cypherpunk Technologies Inc. с 2017 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -31.92%
2025 -58.69%
2024 -5.41%
2023 -33.87%
2022 -82.32%
2021 38.52%
2020 121.83%
2019 -68.29%
2018 -56.56%
2017 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$770.45 7.08%
CH